Topline results from the SURPASS-CVOT trial show that once-weekly tirzepatide has a cardiovascular risk profile similar to ...

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight, food intake and many measures of appetite more than placebo and ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with overweight or obesity, outperforming liraglutide and placebo. Brain ...

PharmaZee’s weight loss program has gained significant attention for its use of GLP-1 agonists, such as Semaglutide and Tirzepatide, which have been scientifically proven to aid in weight loss ...

New research compared the effect of semaglutide vs. tirzepatide on weight loss over a 72 week period. Here's what the study found, and what a doctor has to say about it.

Both GLP-1 drugs, semaglutide is the active ingredient in popular weight-loss drug found in Ozempic and Wegovy, while tirzepatide can be found in Mounjaro and Zepbound.

The mean decrease in waist circumference for those on tirzepatide was 18.4 cm/7.2 in, and for those on semaglutide it was 13 cm/5.1 in – 42% higher for tirzepatide.

We're excited with the results, which demonstrated that low-dose bremelanotide matched tirzepatide in appetite suppression, a compelling outcome," said Carl Spana, Ph.D., President and CEO of Palatin.

BATON ROUGE, La. – Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight, food intake and many measures of appetite ...

We're excited with the results, which demonstrated that low-dose bremelanotide matched tirzepatide in appetite suppression, a compelling outcome," said Carl Spana, Ph.D., President and CEO of Palatin.